申请人:Hoffmann-La Roche Inc.
                            
                            
                                公开号:US08063085B2
                            
                            
                                公开(公告)日:2011-11-22
                            
                            
The present invention relates to compounds of the formula
methods for the preparation thereof, and methods for their use. The compounds are useful in treating diseases characterized by the hyperactivity of MEK. Accordingly the compounds are useful in the treatment of diseases, such as cancer, cognitive and CNS disorders, and inflammatory/autoimmune diseases.
                            本发明涉及公式化合物的方法,其制备方法以及其使用方法。该化合物在治疗MEK高活性所表征的疾病方面具有用途。因此,该化合物在治疗癌症、认知和中枢神经系统疾病以及炎症/自身免疫性疾病方面具有用途。